Enzyme pills for severe pancreas damage
Part of Digestive system clinical trials.
This trial tests if taking pancreatic enzyme pills can help people who have lost weight after a severe first-time pancreas attack with more than half of the organ damaged. It aims to see if the pills improve nutrition and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had your first severe pancreas attack with more than half of the tissue damaged
- You lost at least 5% of your body weight because of the attack
- It has been 6 weeks or less since the attack started
- You can eat food by mouth (no feeding tube needed)
- You are between 18 and 60 years old
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different doses of a pancreatic enzyme pill to help people who have trouble digesting food after stomach or pancreas surgery. If you've had such surgery and struggle with diarrhea or greasy stools, this study may help improve your digestion.
This trial tests whether a medicine called PERT (pancreatic enzyme replacement therapy) helps people with severe acute pancreatitis who have lost pancreatic tissue (necrosis) and significant body weight. The goal is to see if replacing missing digestive enzymes improves nutrition and recovery.
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
This study tests a protein drink with digestive enzymes for people with chronic pancreatitis who are underweight. It aims to help improve nutrition and weight.
This study tests a new digestive enzyme supplement (NHS7108) in adults whose pancreas doesn't make enough enzymes to digest food properly. The trial evaluates whether this new treatment is safe and helps improve fat digestion better than current treatments.
This study tests whether adding pancreatic digestive enzymes to tube feeding can improve digestion and outcomes in critically ill adults who have higher risk of not producing enough digestive enzymes. If you qualify, you may receive the enzyme supplement or a comparison treatment while you’re in the ICU.
Hear when a new Acute Necrotizing Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.